Arthur He analyst

Currently out of the existing stock ratings of Arthur He, 105 are a BUY (95.45%), 5 are a HOLD (4.55%).

Arthur He

Work Performance Price Targets & Ratings Chart

Analyst Arthur He, has had 15.62% of price targets met with an average potential upside of 72.54%, reached in 83 days on average. Previously, Arthur He worked at HC WAINWRIGHT.

Arthur He has documented 193 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PRME, Prime Medicine.

Wall Street Analyst Arthur He

Analyst best performing recommendations are on NKTR.
The best stock recommendation documented was for NKTR on 5/12/2025. The price target of $97.45 was fulfilled within 343 days with a profit of $86.73 (809.05%), with a performance score of 23.59.

Average potential price target upside

SLDB Solid Biosciences LLC ADAG Adagene AUPH BCAB CALT Calliditas Therapeutics LVTX LAVA Therapeutics NV NKTR PRME Prime Medicine PSTX VERA Vera Therapeutics HOOK Hookipa Pharma JBIO

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Mar-2024

$25

$18.75 (300.00%)

$25

2 months 7 days ago
(14-Sep-2026)

0/11 (0%)

$16.26 (186.04%)

Buy Since 11-Nov-2024

$11

$4.75 (76.00%)

$12

6 months 2 days ago
(19-May-2026)

5/8 (62.5%)

$4.92 (80.92%)

156

Buy Since 12-Dec-2024

$16

$9.75 (156.00%)

$16

6 months 3 days ago
(18-May-2026)

0/6 (0%)

$9.49 (145.78%)

Buy Since 21-Jun-2024

$18

$11.75 (188.00%)

$17

6 months 8 days ago
(13-May-2026)

0/3 (0%)

$10.62 (143.90%)

Buy Since 04-Dec-2025

$19

$9.71 (104.52%)

$16

8 months 1 days ago
(20-Mar-2026)

0/4 (0%)

$11.97 (170.27%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Arthur He most bullish on?

Potential upside of $154.8 has been obtained for NKTR

Which stock is Arthur He most reserved on?

Potential downside of $4.45 has been obtained for PRME (PRIME MEDICINE)
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?